Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis ; volume:1 ; number:1 ; day:26 ; month:10 ; year:1999 ; pages:1-11 ; date:6.1999
Arthritis Research & Therapy ; 1, Heft 1 (26.10.1999), 1-11, 6.1999
- Creator
-
Joosten, Leo AB
- Contributor
-
Lubberts, Erik
Helsen, Monique MA
Saxne, Tore
Coenen-de Roo, Christina JJ
Heinegård, Dick
van den Berg, Wim B.
SpringerLink (Online service)
- DOI
-
10.1186/ar14
- URN
-
urn:nbn:de:1111-2016050240302
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Joosten, Leo AB
- Lubberts, Erik
- Helsen, Monique MA
- Saxne, Tore
- Coenen-de Roo, Christina JJ
- Heinegård, Dick
- van den Berg, Wim B.
- SpringerLink (Online service)
Other Objects (12)
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Perforin deficiency attenuates collagen-induced arthritis
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
Neuraminidase inhibitor zanamivir ameliorates collagen-induced arthritis
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Collagen-Induced Platelet Aggregation: Involvement of Endogenous Phosphorylation
Cartilage destruction by matrix degradation products
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
Therapeutic effects of dracocephalum heterophyllum in collagen-induced arthritis
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Perforin deficiency attenuates collagen-induced arthritis
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
Neuraminidase inhibitor zanamivir ameliorates collagen-induced arthritis
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Collagen-Induced Platelet Aggregation: Involvement of Endogenous Phosphorylation
Cartilage destruction by matrix degradation products
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
Therapeutic effects of dracocephalum heterophyllum in collagen-induced arthritis
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis
Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Perforin deficiency attenuates collagen-induced arthritis
Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis
Neuraminidase inhibitor zanamivir ameliorates collagen-induced arthritis
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
Collagen-Induced Platelet Aggregation: Involvement of Endogenous Phosphorylation
Cartilage destruction by matrix degradation products
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4